23andMe is in a death spiral. Almost everyone who wants a DNA test already bought one, a nightmare data breach ruined the company’s reputation, and 23andMe’s stock is so close to worthless it might get kicked off the Nasdaq. CEO Anne Wojcicki is on a crisis tour, promising investors the company isn’t going out of business because she has a new plan: 23andMe is going to double down on mining your DNA data and selling it to pharmaceutical companies.
Worse, the appeal of a DNA test for most people is the novelty of ancestry results, but if your brother already paid for a test, you already know the answers. 23andMe knows that’s an issue, so it’s spent years trying to brand itself as a healthcare service, and not just a $79 permission slip to tell people you’re Irish. In fact, the company thinks you should buy yourself a recurring annual subscription to something called 23andMe+ Total Health. It only costs $1,188 a year.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WIRED - 🏆 555. / 51 Read more »